Bgm (BGM) EPS (Basic) Growth (3y) (2022 - 2025)
Bgm (BGM) EPS (Basic) Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 50.53% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 6.20% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -70.04% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | 6.69% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -6.51% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 65.05% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -18.26% |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -99.09% |
| Sep 30, 2024 | -99.10% |
| Sep 30, 2023 | 11.22% |
| Sep 30, 2022 | 30.80% |